GLP-1 side effects and weight loss claims: what the data says

What did @melissasmanual actually say?

Honestly? Nothing. Not a single medical claim appears in this video. The transcript is song lyrics, or possibly garbled audio that a transcription tool attempted to interpret. Lines like "I'm a sea of demons" and "seeking my come between us again" are not GLP-1 advice. They are not advice at all. There is nothing here to fact-check in the traditional sense, and pretending otherwise would be its own kind of misinformation.

The video is categorized under GLP-1 receptor agonists, which include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). But the content, at least as transcribed, contains zero references to dosing, weight loss, side effects, compounding, or any health topic. Either the audio was misread by the transcription software, or this is a lifestyle/mood post that happens to live in a GLP-1 content category.

Does the science back this up?

There is no claim here to evaluate against the literature. But since this video is filed under GLP-1 content, it is worth briefly noting what the actual science says about this drug class, so readers have a baseline for comparison when they do encounter real claims in this space.

GLP-1 receptor agonists have a meaningful body of clinical evidence behind them. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found that semaglutide 2.4 mg weekly produced an average body weight reduction of about 14.9% over 68 weeks in adults with obesity. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide at the highest dose produced up to 20.9% weight reduction. These are real, peer-reviewed findings. Any creator in this space making claims that contradict or dramatically exceed these benchmarks should be questioned.

What did they get wrong (or right)?

This is an unusual position to be in: there is nothing to correct and nothing to credit. The creator said nothing medically actionable. If anything, the absence of health claims is, by default, safer than what many GLP-1 creators produce. The bar in this content category is low enough that "said nothing" qualifies as not causing harm.

That said, context matters. If this video is part of a series where @melissasmanual regularly discusses GLP-1 medications, the surrounding content may contain real claims worth scrutinizing. A single video tagged to a health category without substantive content is not necessarily a red flag, but it does make fact-checking impossible in any meaningful way. The honest call here is to flag the lack of verifiable content rather than manufacture a verdict.

What should you actually know?

If you landed on this fact-check hoping to understand GLP-1 medications better, here is what is worth knowing independent of this video. These drugs work by mimicking a naturally occurring hormone that regulates appetite and blood sugar. They are not magic, and they are not without risk. Common side effects include nausea, vomiting, and gastrointestinal discomfort, particularly during dose escalation (Davies et al., 2021, Lancet).

Compounded versions of semaglutide and tirzepatide have circulated widely due to brand-name shortages. Compounded drugs are not FDA-approved and are not equivalent to brand-name versions. Potency, purity, and safety profiles can vary. The FDA has issued multiple warnings on this point. If a creator, any creator, tells you that a compounded peptide is the same as Wegovy or Zepbound, that claim is inaccurate and you should treat it skeptically.

When evaluating GLP-1 content on TikTok, look for creators who cite actual trials, acknowledge side effects, and avoid absolute language about outcomes. The evidence in this space is strong but not unlimited, and anyone promising guaranteed results is not reading the same studies the researchers are.